Cargando…

Diffuse myocardial fibrosis, but not focal fibrosis identified with delayed enhancement, is an independent predictor of LV reversed remodeling in patients with idiopathic non-ischemic cardiomyopathy

Detalles Bibliográficos
Autores principales:	Yingchoncharoen, Teerapat, Flamm, Scott D, Kwon, Deborah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559662/ http://dx.doi.org/10.1186/1532-429X-15-S1-P109

Ejemplares similares

Interrelationship of LV mass, focal fibrosis by LGE, and diffuse fibrosis by T1-changes in patients with hypertrophic cardiomyopathy
por: Potluri, Rahul, et al.
Publicado: (2012)

Right ventricular T1 mapping is technically feasible and correlates with right ventricular dysfunction in non-ischemic cardiomyopathy
por: Jellis, Christine, et al.
Publicado: (2014)

Is there concordance between LV fibrosis and RV fibrosis in patients with hypertrophic cardiomyopathy; should there be?
por: Amin, Nessim N, et al.
Publicado: (2014)

Going beyond ejection fraction - CMR assessment of ventricular-vascular coupling and LV remodeling predicts diastolic dysfunction in advanced ischemic cardiomyopathy
por: Cavalcante, Joao L, et al.
Publicado: (2013)

Degree of diffuse fibrosis measured by MRI correlates with LV remodelling in childhood cancer survivors after anthracycline chemotherapy
por: Tham, Edythe B, et al.
Publicado: (2011)

Recent advances in hypertrophic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Focal scar and diffuse myocardial fibrosis are independent imaging markers in repaired tetralogy of Fallot
por: Cochet, Hubert, et al.
Publicado: (2019)

Markers of Focal and Diffuse Nonischemic Myocardial Fibrosis Are Associated With Adverse Cardiac Remodeling and Prognosis in Patients With Hypertension: The REMODEL Study
por: Iyer, Nithin R., et al.
Publicado: (2022)

Identification of target genes in cardiomyopathy with fibrosis and cardiac remodeling
por: Zhao, Jianquan, et al.
Publicado: (2018)

Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
por: Hussain, Tarique, et al.
Publicado: (2013)

Reproducibility of multiple T1 Mapping techniques and to ECV quantification
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Delayed myocardial enhancement in pediatric hypertrophic cardiomyopathy: correlation with LV functional and demographic parameters
por: Behairy, Noha, et al.
Publicado: (2016)

Risk factors for diagnostic delay in idiopathic pulmonary fibrosis
por: Hoyer, Nils, et al.
Publicado: (2019)

LV geometric and substrate remodelling in patient with Ebstein anomaly - a deep insight from MRI T1 mapping fibrosis imaging
por: Yang, Dan, et al.
Publicado: (2016)

Right ventricular function in dilated cardiomyopathy: relation to location of focal myocardial fibrosis
por: Abdelrazek, Mohamed A, et al.
Publicado: (2013)

If there is LV myocardial fibrosis should we expect to find RV myocardial fibrosis? A cardiovascular MRI study
por: Biederman, Robert W, et al.
Publicado: (2012)

Mechanical effects of midwall fibrosis in non-ischemic dilated cardiomyopathy
por: Taylor, Robin J, et al.
Publicado: (2014)

Pathophysiology of LV Remodeling Following STEMI: A Longitudinal Diffusion Tensor CMR Study
por: Das, Arka, et al.
Publicado: (2023)

The inter-connection between fibrosis and microvascular remodeling in idiopathic pulmonary fibrosis: Reality or just a phenomenon
por: Mlika, Mona, et al.
Publicado: (2015)

Does RV fibrosis have an effect on mortality in patients hypertrophic cardiomyopathy? An LV vs. RV national death index (NDI) study
por: Biederman, Robert W, et al.
Publicado: (2015)

Potential Delays in Diagnosis of Idiopathic Pulmonary Fibrosis in Medicare Beneficiaries
por: Mooney, Joshua, et al.
Publicado: (2019)

CMR feature tracking in patients with dilated cardiomyopathy: patterns of myocardial strain and focal fibrosis
por: Chevalier, Céleste, et al.
Publicado: (2022)

Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis
por: Tjin, Gavin, et al.
Publicado: (2017)

CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis
por: Lipson, Kenneth E, et al.
Publicado: (2012)

Aetiology of Heart Failure, Rather than Sex, Determines Reverse LV Remodelling Response to CRT
por: Said, Fatema, et al.
Publicado: (2021)

The effect of long-term amiodarone administration on myocardial fibrosis and evolution of left ventricular remodeling in a porcine model of ischemic cardiomyopathy
por: Zagorianou, Anastasia, et al.
Publicado: (2016)

Assessment of left ventricular twist mechanics by speckle tracking echocardiography reveals association between LV twist and myocardial fibrosis in patients with hypertrophic cardiomyopathy
por: Zhang, Hong-Ju, et al.
Publicado: (2014)

Mechanical effects of left ventricular midwall fibrosis in non-ischemic cardiomyopathy
por: Taylor, Robin J., et al.
Publicado: (2016)

The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients
por: El-khodary, Noha M., et al.
Publicado: (2022)

Non-ischemic cardiomyopathy with focal segmental glomerulosclerosis
por: Kaur, Parminder, et al.
Publicado: (2020)

Initial evidence of presence of papillary muscle diffuse fibrosis in patients with cardiomyopathy
por: Kato, Shingo, et al.
Publicado: (2015)

Prognostic Significance of Nonischemic Myocardial Fibrosis in Patients With Normal LV Volumes and Ejection-Fraction
por: Lota, Amrit S., et al.
Publicado: (2021)

Native T1 mapping in patients with idiopathic dilated cardiomyopathy for the assessment of diffuse myocardial fibrosis: validation against histologic endomyocardial biopsy
por: Goto, Yoshitaka, et al.
Publicado: (2015)

Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy
por: Díez-López, Carles, et al.
Publicado: (2022)

Multi-Step Extracellular Matrix Remodelling and Stiffening in the Development of Idiopathic Pulmonary Fibrosis
por: Júnior, Constança, et al.
Publicado: (2023)

Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart
por: Zhu, Feng, et al.
Publicado: (2022)

Prognostic implication of liver fibrosis scores in patients with non-ischemic dilated cardiomyopathy
por: Liu, Yupeng, et al.
Publicado: (2023)

Sex differences in atrial remodeling and its relationship with myocardial fibrosis in hypertrophic obstructive cardiomyopathy
por: Bi, Xuanye, et al.
Publicado: (2022)

Independent Clinical Factors Relevant to Prognosis of Patients with Idiopathic Pulmonary Fibrosis
por: Song, Huifang, et al.
Publicado: (2019)

Mid-wall fibrosis on delayed enhancement CMR - a marker for adverse left ventricular chamber remodeling independent of cardiomyopathic etiology
por: Kim, Jiwon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cg5upuh0gsdq545s2l1jarjoss